Skip to site menu Skip to page content

Daily Newsletter

22 August 2023

Daily Newsletter

22 August 2023

IARC opens new detox and residential treatment centre in Webster

This facility is intended to increase access to care for substance use disorders in the Houston area.

August 21 2023

Houston, Texas-based addiction treatment centre Into Action Recovery Centers (IARC) has launched a new 37-bed Detox and Residential Treatment Center in Webster.

This expansion is intended to increase access to care for substance use disorders in the Houston area.

IARC co-founder and CEO Shane Leonard said: “This is the next step in building an all-inclusive behavioural healthcare company.

“Without question, our phenomenal staff and the "Client First Commitment" we have always had, and now with even more resources and capacity, I have no problem saying that there is no other company in the industry that can deliver like we do!

“And now that we have a high-end experience to offer, that is still the best value in the country, we like where we are and will continue to seek out opportunities to better serve our beloved clients.”

The new facility is adjacent to the group’s current 48-bed centre and marks its third expansion in six years.

IARC co-founder and director Prissy Leonard said: “We are not backed by a giant Wall Street firm as we are a family owned company.

“It can be nerve-wracking to try and compete with all the new companies with the financial resources they have at their disposal and you can only imagine how risky large scale expansion can be for us.

“What separates us from them is our amazing staff and the unrelenting support of our alumni, who we love dearly.”

Generative AI set to transform the medical devices industry

GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close